title: Screening for ovarian cancer in women with breast cancer with transvaginal sonography and color flow imaging.
abstract: The aim of the present study was to determine the efficacy of transvaginal color flow imaging as a screening tool for ovarian cancer. Six hundred patients with previous breast carcinoma were screened for ovarian cancer. Screening was performed using transvaginal sonography with color flow imaging. Serum CA 125 levels were measured in patients with abnormal sonographic findings. Eighty-three percent of the ovaries were detected in the premenopausal patients by ultrasonographic scanning and only 26% of the ovaries were detected in the postmenopausal patients. Intraovarian blood vessels were detected in 11% of the premenopausal women. The PI was less than 1 in 80% of these ovaries, but, on repeated examinations, the values of PI increased in all the blood vessels to greater than 1. Intraovarian blood vessels were detected in 1.8% of the normal ovaries observed in the postmenopausal women, but PI was always greater than 1. Eleven women with complex ovarian cysts (not simple) and one woman with enlarged ovaries underwent explorative laparotomy. In three women, primary malignant ovarian tumors were diagnosed and in one woman metastatic ovarian cancer was diagnosed. The specificity of sonography in detecting malignant ovarian tumors was 97.5% and the positive predictive value was 25%. The specificity of color flow imaging in detecting primary malignant ovarian tumors was 99.8% and the positive predictive value was 60%. In selected groups of women, screening for ovarian cancer with transvaginal color flow imaging may be justified.
authors.affiliation: Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel.
authors.forename: Z
authors.initials: Z
authors.lastname: Weiner
authors.forename: D
authors.initials: D
authors.lastname: Beck
authors.forename: M
authors.initials: M
authors.lastname: Shteiner
authors.forename: R
authors.initials: R
authors.lastname: Borovik
authors.forename: M
authors.initials: M
authors.lastname: Ben-Shachar
authors.forename: E
authors.initials: E
authors.lastname: Robinzon
authors.forename: J M
authors.initials: JM
authors.lastname: Brandes
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D001943:Breast Neoplasms / Q000150:complications* / Q000628:therapy; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D006984:Hypertrophy / Q000000981:diagnostic imaging; D008593:Menopause; D008875:Middle Aged; D010048:Ovarian Cysts / Q000000981:diagnostic imaging; D010051:Ovarian Neoplasms / Q000097:blood / Q000000981:diagnostic imaging*; D010053:Ovary / Q000000981:diagnostic imaging / Q000473:pathology; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D014463:Ultrasonography
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate